Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Juan P. Bosch is active.

Publication


Featured researches published by Juan P. Bosch.


Annals of Internal Medicine | 1999

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Andrew S. Levey; Juan P. Bosch; Julia B. Lewis; Tom Greene; Nancy Rogers; David Roth

The glomerular filtration rate (GFR) is traditionally considered the best overall index of renal function in health and disease (1). Because GFR is difficult to measure in clinical practice, most clinicians estimate the GFR from the serum creatinine concentration. However, the accuracy of this estimate is limited because the serum creatinine concentration is affected by factors other than creatinine filtration (2, 3). To circumvent these limitations, several formulas have been developed to estimate creatinine clearance from serum creatinine concentration, age, sex, and body size (4-12). Despite more recent studies that have related serum creatinine concentration to GFR (13-24), no formula is more widely used to predict creatinine clearance than that proposed by Cockcroft and Gault (4). This formula is used to detect the onset of renal insufficiency, to adjust the dose of drugs excreted by the kidney, and to evaluate the effectiveness of therapy for progressive renal disease. More recently, it has been used to document eligibility for reimbursement from the Medicare End Stage Renal Disease Program (25) and for accrual of points for patients on the waiting list for cadaveric renal transplantation (26). Major clinical decisions in general medicine, geriatrics, and oncology (as well as nephrology) are made by using the Cockcroft-Gault formula and other formulas to predict the level of renal function. Therefore, these formulas must predict GFR as accurately as possible. The Modification of Diet in Renal Disease (MDRD) Study, a multicenter, controlled trial, evaluated the effect of dietary protein restriction and strict blood pressure control on the progression of renal disease (27-30). During the baseline period, GFR, serum creatinine, and several variables that affect the relation between them were measured in patients with chronic renal disease. The purpose of our study was to develop an equation from MDRD Study data that could improve the prediction of GFR from serum creatinine concentration. Methods Baseline Cohort and Measurement Methods in the Modification of Diet in Renal Disease Study The overall study design and methods of recruitment for the MDRD Study have been described elsewhere (31, 32). A total of 1785 patients entered the baseline period. Of these patients, 1628 (91%) also underwent measurement of GFR and the other variables described below; these patients constitute the study group for these analyses. Glomerular filtration rate was measured as the renal clearance of 125I-iothalamate (33, 34). Creatinine clearance was computed from creatinine excretion in a 24-hour urine collection and a single measurement of serum creatinine. Serum and urine creatinine were measured by using a kinetic alkaline picrate assay with a normal range in serum of 62 to 124 mol/L (0.7 to 1.4 mg/dL) (35). Glomerular filtration rate and creatinine clearance were expressed per 1.73 m2 of body surface area by multiplying measured values by 1.73/body surface area (36). The serum and urine specimens were also used for other measurements, including serum albumin (bromcresol green method [35]), serum urea nitrogen (urease method [35]), and urine urea nitrogen (urease method [35]). Protein intake (g/d) was estimated as 6.25 [UUN (g/d) + 0.031 (g/kg per day) SBW (kg)], where UUN is urine urea nitrogen, SBW is standard body weight, and 0.031 g/kg per day is a constant reflecting the rate of excretion of nitrogen in compounds other than urine urea (37, 38). The diagnosis of diabetes and the cause of renal disease were assigned on the basis of chart review at the clinical center (39). Statistical Analysis Descriptive Statistics The relation of renal function measurements to other baseline characteristics was assessed by using contingency tables, t-tests, analysis of variance, and linear regression, as appropriate. Nonparametric tests (Wilcoxon rank-sum tests and Kruskal-Wallis tests) gave consistent results. A P value less than 0.01 was considered statistically significant. Multivariable Analysis of Glomerular Filtration Rate We used stepwise multiple regression to determine a set of variables that jointly predicted GFR. The stepwise regression models were developed by using a training sample consisting of a random sample of 1070 of the 1628 patients. We found that the variability of the difference between the observed and predicted GFR values was greater for higher GFR values. This increase was eliminated by performing multiple regressions on log-transformed data. To facilitate clinical interpretation, the results were re-expressed in terms of the original units. Consequently, the prediction equation is a multiplicative model; regression coefficients refer to the change in geometric mean GFR associated with unit changes in the independent variable. Predicted GFR is expressed in mL/min per 1.73 m2. The following variables were considered for possible inclusion in the regression model: weight, height, sex, ethnicity, age, diagnosis of diabetes, serum creatinine concentration, serum urea nitrogen level, serum albumin level, serum phosphorus level, serum calcium level, mean arterial pressure, urine creatinine level, urine urea nitrogen level, urine protein level, and urine phosphorus level. The cause of renal disease was not included because in clinical practice, the cause may be unknown or clinicians may not use the same classification method as the investigators in the MDRD Study. A P value less than 0.001 was used as the criterion for entry of a variable into the model. Because of the difficulty in collecting complete 24-hour urine samples in clinical practice, an additional stepwise regression was performed to develop a prediction model that did not include urine biochemistry variables. Finally, because of the interest in developing a prediction equation to assess eligibility for Medicare reimbursement and listing for cadaveric renal transplantation, we repeated the analysis restricting the population to the subgroup of patients with higher serum creatinine concentrations (>221 mol/L [2.5 mg/dL]; n=509 in the training sample). Methods for Comparing Equations To Predict Glomerular Filtration Rate We first developed coefficients for each prediction equation (including the selection of the predictor variables for the stepwise regressions) using the data from the training sample to predict log GFR. Each prediction equation also included a multiplicative constant to account for any consistent bias in the application of that equation in the MDRD Study Group. This was particularly important for equations that are intended to estimate creatinine clearance, which is known to be higher than GFR. The regression coefficients determined in the training sample were then applied to obtain predicted GFRs in a separate validation sample consisting of the remaining 558 patients (172 patients with serum creatinine concentration>221 mol/L [2.5 mg/dL]). These predicted GFR values were compared with the actual GFRs in the validation sample to evaluate the performance of each prediction equation. In this way, separate data sets were used to construct the equations and assess their accuracy after removal of systematic bias. For each equation, we computed overall R 2 (percentage of variability in log GFR explained by the regression model) and the 50th, 75th, and 90th percentiles of the distribution of the percentage absolute difference between measured and predicted GFRs in the validation sample. The 50th percentiles indicate the typical size of the errors in prediction of GFR, and the 75th and 90th percentiles assess the sizes of the larger errors that occurred for each model. Development of Final Prediction Equations To improve the accuracy of the final MDRD Study prediction equations, the regression coefficients derived from the training sample were updated on the basis of data from all 1628 patients. As a result, the standard errors of the regression coefficients in the final MDRD Study prediction equations are slightly smaller than those derived from the training sample; thus, the accuracy of the final prediction equations may be slightly better (by about 0.1% to 0.2%) than their accuracy as assessed in the validation sample. Results Demographic and Clinical Characteristics The mean age ( SD) of the cohort was 50.6 12.7 years. Sixty percent of patients were male, 88% were white, and 6% were diabetic. Causes of renal disease were glomerular disease (32%), polycystic kidney disease (22%), tubulointerstitial disease (7%), and other or unknown renal diseases (40%). Mean protein intake was 0.99 0.24 g/kg of body weight per day and mean arterial pressure was 99.4 12.2 mm Hg. Mean weight was 79.6 16.8 kg, body surface area was 1.91 0.23 m2, serum urea nitrogen concentration was 11.4 5.7 mmol/L [32 16 mg/dL], and serum albumin concentration was 40.0 4.0 g/L [4.0 0.4 g/dL], respectively. Glomerular Filtration Rate, Creatinine Clearance, and Serum Creatinine Concentration Renal function measurements for the study group and for various subgroups are shown in Table 1. Mean GFR for the population was 0.38 mL s 2 m 2 (39.8 mL/min per 1.73 m2), with lower values in patients with lower protein intake, white patients compared with black patients, and older patients ( 55 years) compared with younger patients (P<0.01). The mean value of creatinine clearance was 0.81 mL s 2 m 2 (48.6 mL/min per 1.73 m2) and was lower in older patients and patients with lower protein intake (P 0.01). The mean serum creatinine concentration was 203 mol/L (2.3 mg/dL) and was higher in men, patients with lower protein intake, and patients with higher mean arterial pressure (P 0.01). Figure 1 shows the well-known reciprocal relation of serum creatinine concentration to GFR for subgroups based on sex and ethnicity. At any given GFR, the serum creatinine concentration is significantly higher in men than in women and in black persons than in white persons (P<0.001). Table 1. Association of Renal Fu


The American Journal of Medicine | 1983

Renal functional reserve in humans: Effect of protein intake on glomerular filtration rate

Juan P. Bosch; Anna Saccaggi; Allan Lauer; Claudio Ronco; Mario Belledonne; Sheldon Glabman

This study was designed to investigate the effect of protein intake on glomerular filtration rate, and to demonstrate and evaluate the functional reserve of the kidney. Normal subjects ingesting a protein diet had a significantly higher creatinine clearance than a comparable group of normal subjects ingesting a vegetarian diet. A progressive increment in protein intake in normal volunteers resulted in a significant increase in creatinine clearance. Diurnal variations in creatinine clearance were found. These daily variations correlated well with the periods of food intake. The capacity of the kidney to increase its level of function with protein intake suggests a renal function reserve. In short-term studies, the effect of a protein load on glomerular filtration rate was evaluated. Normal subjects showed an increase in glomerular filtration rate two and a half hours after protein load to a maximal glomerular filtration rate of 171.0 +/- 7.7 ml per minute. In patients with a reduced number of nephrons, renal functional reserve may be diminished or absent.


Annals of Internal Medicine | 1983

Continuous Arteriovenous Hemofiltration in the Critically Ill Patient: Clinical Use and Operational Characteristics

Allan Lauer; Anna Saccaggi; Claudio Ronco; Mario Belledonne; Sheldon Glabman; Juan P. Bosch

Continuous arteriovenous hemofiltration is an extracorporeal technique for the treatment of fluid overload and electrolyte disturbances and for the removal of urea nitrogen. This technique is especially applicable in critically ill patients with hemodynamic instability. A special filter and modified hemodialysis blood lines can easily and rapidly be attached to a patient. No special blood access is needed. Fluids and solutes are removed from the patient by ultrafiltration. A net filtration pressure inside the filter causes an ultrafiltrate to form. The extracorporeal circuit can be kept in place for hours or days.


The American Journal of Medicine | 1984

Short-term protein loading in assessment of patients with renal disease☆

Juan P. Bosch; Allan Lauer; Sheldon Glabman

The effect of short-term protein loading on the glomerular filtration rate in normal persons and patients with renal disease was evaluated. Previous studies have demonstrated that in healthy subjects, protein loading results in an increased glomerular filtration rate. By determining the glomerular filtration rate preceding (baseline glomerular filtration rate) and following (test glomerular filtration rate) oral protein loading, it was possible to define (1) the filtration capacity (test glomerular filtration rate) and (2) the renal reserve (test glomerular filtration rate - baseline glomerular filtration rate) of the kidney. In normal persons, filtration capacity averaged 157 +/- 13 ml per minute and renal reserve 34 ml per minute. The test glomerular filtration rate was reproducible and independent of protein intake, whereas baseline glomerular filtration rate was significantly influenced by diet. Patients with renal disease were found to have a reduced renal reserve and/or a diminished filtration capacity. The reduction in filtration capacity appears to correlate with the damage sustained by the organ. It is suggested that an abnormal response to protein loading in renal disease may herald the fall in the baseline glomerular filtration rate and the rise in plasma creatinine level.


Seminars in Dialysis | 2007

Should Hemodialysis Fluid Be Sterile

Juan P. Bosch

In conclusion we would like to stress that mastering water treatment techniques in dialysis centers offers the potential for technological advances and improved care. It permits the routine production of SPF dialysis fluid and infusate for HD and for HF. The use of SPF water also improves the safety of cleansing and reconditioning procedures in dialyzer reuse, upgrading this technique to a high quality standard. In our hands, the overall cost of producing ultrapure water and SPF electrolyte solutions, including disinfection procedures, ultrafilter device, and microbiological monitoring, amount to approximately FF40 per session (U.S.


Archive | 1999

Annals of Internal Medicine A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Andrew S. Levey; Juan P. Bosch; Julia Breyer Lewis; Tom Greene; Nancy Rogers; David Roth

7-8). The reuse of polysulfone dialyzers, as practiced in our dialysis unit ( 17), limits the cost of a HDF session to FFll50 (approximately U.S.


Journal of The American Society of Nephrology | 1996

Effects of Diet and Antihypertensive Therapy on Creatinine Clearance and Serum Creatinine Concentration in the Modification of Diet in Renal Disease Study

Andrew S. Levey; Juan P. Bosch; Cecil H. Coggins; Tom Greene; William E. Mitch; Mark Schluchter; Steven J. Schwab

205) while allowing our patients to receive a new, high-efficiency dialytic approach ( 18) which provides improved cardiovascular stability ( 19). Whether this “new HD” will prevent (or delay) the long-term complications observed with “conventional HD” will take several years to demonstrate.


Archives of Surgery | 1986

Double-Lumen, Silicone Rubber, Indwelling Venous Catheters: A New Modality for Angioaccess

Harry Schanzer; Steven R. Kaplan; Juan P. Bosch; Sheldon Glabman; Lewis Burrows


Archive | 1986

Response to Protein Loading in Normal and Diseased Kidneys

Juan P. Bosch; Susie Lew; Allan Lauer


Seminars in Dialysis | 2007

High‐Efficiency Short‐Time Dialysis Is Safe and Will Replace Conventional Hemodialysis

Juan P. Bosch

Collaboration


Dive into the Juan P. Bosch's collaboration.

Top Co-Authors

Avatar

Allan Lauer

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Sheldon Glabman

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mario Belledonne

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harry Schanzer

Icahn School of Medicine at Mount Sinai

View shared research outputs
Researchain Logo
Decentralizing Knowledge